This compound is a pharmaceutical reference impurity, specifically a derivative of afatinib, characterized by a quinazoline core with chlorofluoroaniline, oxolan-3-yloxy, and hydroxypyrrolidinone substituents. It is used primarily as a reference standard in quality control and analytical testing for afatinib-related pharmaceuticals.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2223677-58-3
4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide--hydrogen chloride (1/1)
pharmaceutical reference impurity
Adrenaline EP Impurity E HCl
pharmaceutical reference impurity
N1,N2-Bis(4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)oxalamide
Pharmaceutical intermediate for Afatinib impurities
(S)-N1-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-N2,N2-DIMETHYLOXALAMIDE
pharmaceutical intermediate
(S)-4-Methyloxazolidine-2,5-dione
pharmaceutical intermediate
1-(4-chlorophenyl)-3-oxoisoindoline
Pharmaceutical intermediate synthesis
1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-5-hydroxypyrrolidin-2-one
HIMWAPFLBWDJMH-SZQRVLIRSA-N
C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)N5C(CCC5=O)O